Evidence map›Paper›PMID 39591179›Full record

ArticleVaccines2024

Hepatitis A Seroprevalence Among HIV-Exposed and Unexposed Pediatric Populations in South Africa.

Edina Amponsah-Dacosta, Lufuno Ratshisusu, Lorato M Modise, Ntombifuthi Blose, Omphile E Simani, Selokela G Selabe, Benjamin M Kagina, Rudzani Muloiwa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Edina Amponsah-DacostaVaccines for Africa Initiative, School of Public Health, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa.ORCID 0000-0002-3913-0457
Lufuno RatshisusuHIV and Hepatitis Research Unit, Department of Virology, Sefako Makgatho Health Sciences University, Pretoria 0208, South Africa.ORCID 0000-0002-7384-4752
Lorato M ModiseHIV and Hepatitis Research Unit, Department of Virology, Sefako Makgatho Health Sciences University, Pretoria 0208, South Africa.
Ntombifuthi BloseHealth Systems Trust, Durban 4001, South Africa.
Omphile E SimaniHIV and Hepatitis Research Unit, Department of Virology, Sefako Makgatho Health Sciences University, Pretoria 0208, South Africa.
Selokela G SelabeHIV and Hepatitis Research Unit, Department of Virology, Sefako Makgatho Health Sciences University, Pretoria 0208, South Africa.ORCID 0000-0001-5101-5198
Benjamin M KaginaVaccines for Africa Initiative, School of Public Health, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa.ORCID 0000-0003-4943-9762
Rudzani MuloiwaVaccines for Africa Initiative, School of Public Health, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa.

Funding

Gilead Sciences (United States) N/A
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

hepatitis Ahepatitis A virusHIVinfantsmaternal antibodySouth Africawater sanitation and hygiene

Identifiers

PMID39591179
PMCPMC11598911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.